Klinikum Fuerth Anstalt des Oeffentlichen Rechts der Stadt Fuerth
- Address
- lock Available on a paid plan
Cardiovascular Diseases
The Klinikum Fuerth Anstalt des Oeffentlichen Rechts der Stadt Fuerth is conducting research on acute heart conditions, focusing on patients with anterior ST‑Elevation Myocardial Infarction. The work aims to improve outcomes after emergency PCI.
- Acute myocardial infarction management
- Heart failure prevention strategies
- Evaluation of novel IV therapeutics
The trial assesses the effect of FDY‑5301 on cardiovascular mortality and heart‑failure events, seeking to establish a new maintenance option for STEMI patients.
Neoplasms – Ovarian Cancer
In the Oncology Division, investigators are studying homologous recombination deficiency advanced ovarian cancer to determine the benefit of targeted maintenance therapy after initial chemotherapy.
- Maintenance treatment after platinum‑based chemotherapy
- Progression‑free survival enhancement
- PARP inhibitor efficacy in high‑risk patients
The study evaluates niraparib versus placebo as a maintenance strategy, aiming to prolong disease control for patients with stage III or IV disease who have responded to first‑line treatment.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Klinikum Fuerth Anstalt des Oeffentlichen Rechts der Stadt Fuerth
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 3 Randomized Double-Blind Placebo-Controlled Study of Intravenous Sodium Iodide (FDY-5301) in Anterior ST-Elevation Myocardial Infarction Patients | Faraday Pharmaceuticals Inc. | Phase III | Not Recruiting | Apr 2022 | May 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Niraparib Tosilate Monohydrate | 1 | Unknown | 2016-09-14 | 2016-09-14 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.